Tumor vaccines: Effects and fate of IL-2 transfected murine melanoma cells in vivo
✍ Scribed by G. Maass; T. Schweighoffer; M. Berger; W. Schmidt; E. Herbst; K. Zatloukal; M. Buschle; M.L. Birnstiel
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 695 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0192-0561
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Curcumin, the active ingredient from the spice turmeric (__Curcuma longa__ Linn), is known to be an anti‐oxidant and an anti‐inflammatory agent. It has been demonstrated recently to possess anti‐angiogenic effects and pro‐apoptotic activities against Ehrlich ascites tumor cells. In the
## Interleukin (1L)-2 activation of p2lraS in murine myeloid cells transfected with human IL-2 receptor p chain The T cell growth factor interleukin-2 (IL-2) induces ~21'"' activation in T lymphocytes. To determine whether the IL-2 receptor (IL-2R) can regulate p2lraS when expressed in a non-Tcell
The interleukin-I (Y (IL-I) gene was introduced by retroviral gene transfer into the A375P human melanoma cell line. Two hygromycin-resistant colonies, colony 3 and colony 6, which respectively do not and do express and release IL-I, were selected on the basis of Northern blot and ELISA. Both coloni